-
1 Comment
Genkyotex SA is currently in a long term downtrend where the price is trading 0.6% below its 200 day moving average.
From a valuation standpoint, the stock is 30.5% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 356.7.
Its net income has dropped by 0.0% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 45.3% to $-1M since the same quarter in the previous year.
Based on the above factors, Genkyotex SA gets an overall score of 0/5.
| CurrencyCode | EUR |
|---|---|
| Industry | Biotechnology |
| Sector | Healthcare |
| ISIN | FR0013399474 |
| Exchange | PA |
| PE Ratio | None |
|---|---|
| Beta | 0.95 |
| Dividend Yield | 0.0% |
| Target Price | 3.9 |
| Market Cap | 45M |
Genkyotex SA, a biopharmaceutical company, develops oral small molecule NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit NOX enzymes amplifying various disease processes, such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company's lead product candidate is GKT831, a NOX1 and NOX4 inhibitor, which is evaluated in a Phase II clinical trial in primary biliary cholangitis a fibrotic orphan disease and in an investigator-initiated Phase II clinical trial in type 1 diabetes and kidney disease. Its preclinical stage product candidate is GKT771, a NOX1 inhibitor targeting various pathways in pain processing and inflammation. Genkyotex SA has a license agreement with Serum Institute of India Ltd. for GTL003, an antigen for use in the development of acellular multivalent combination vaccines against a variety of infectious diseases. The company was founded in 2006 and is headquartered in Labège, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GKTX.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
